New Products

NORTH WALES, Pa. — Teva Pharmaceuticals has launched a chewable birth control pill, the generic drug maker said Friday.

Teva announced the launch of Zeosa (norethindrone and ethinyl estradiol) tablets.

The drug is chemically equivalent to Warner Chilcott’s Femcon Fe tablets and is available in the 0.4 mg/0.035 mg strength.

HOLLYWOOD, Fla. — MB Innovations on Monday launched a new weight loss supplement called Slimple. 

Slimple contains MaCoca, a proprietary blend derived from a de-cocainized coca leaf. 

The extract is processed using a method that carefully removes the alkaloids while retaining all of the active ingredients, enabling it to be legally used as a food additive, the company stated. According to MB Innovations, the coca leaf contains flavonoids, triterpenoids, vitamin C, amino acids, carotenoids, vitamin B complex and essential oils. 

LOS ANGELES, Calif. — If you’re looking for some comedic relief this summer, let Louis C.K. headline in your own home with Season 1 of “Louie,” the FX comedy TV series starring Louis C.K. as a successful stand-up comedian and newly single father raising two daughters in New York.

PURCHASE, N.Y. — PepsiCo is launching its latest Propel drink with the same great taste and a pretty face; Cindy Crawford is representing Propel Zero, the zero-calorie, enhanced water with no artificial flavors and no heavy sweeteners, in the brand's new campaign that begins this week.

MORRISTOWN, N.J. — A generic painkiller made by Watson Pharmaceuticals infringes a patent covering the branded version, a U.S. District Court ruled.

Watson said Friday that the U.S. District Court for the District of Delaware decided that Watson’s generic version of Cephalon’s Fentora (fentanyl) buccal tablets infringes U.S. Patent No. 6,264,981, though the Food and Drug Administration had approved Watson’s version of the drug.

NATIONAL HARBOR, Md. — A pill developed by AstraZeneca and Pozen that combines a nonsteroidal anti-inflammatory drug with a proton-pump inhibitor was well-tolerated in patients with osteoarthritis, according to a new study.

AstraZeneca announced results of PN400-304, a 12-month study of Vimovo (naproxen and esomeprazole magnesium) delayed-release tablets in patients with osteoarthritis who need daily treatment with NSAIDs but are at risk of NSAID-related gastric ulcers. Vimovo is designed to reduce pain while reducing gastric ulcer risk.

CLEVELAND — American Greetings is making kids' birthday cards extra special with its Surprise Inside line.

Each Surprise Inside card features a surprise gift pouch that the child can open to reveal a small toy that coordinates with the card's theme, the company said. A sticker reveals to the sender what the secret gift will be.

SILVER SPRING, Md. — The Food and Drug Administration has approved a new treatment for late-stage skin cancer, the agency said Friday.

The FDA approved Bristol-Myers Squibb’s Yervoy (ipilimumab) for patients with melanoma that has spread to other parts of the body, also known as metastasis. More than 68,000 new cases of melanoma were diagnosed in the United States in 2010, and about 8,700 died from it, according to the National Cancer Institute, part of the National Institutes of Health.